Advanced Instrumentation Testbed (AIT) - antiNeutrino Experiment One (NEO) (Q1 FY2021)
In anticipation of the planned June 2021 design review, conceptual design, costing, and documentation efforts continued. The quarter was highlighted by the completion of three significant milestones: 1) 50% conceptual design and costing of the AIT facility, 2) bottom-up cost estimates for NEO, and 3) parametric NEO performance estimates (via the Big Trade Study). Because cost estimates exceed available funding levels, the project team started (late Dec 2020) a value engineering/pivot exercise to align costs with available funds. This exercise is anticipated to consume the project team for most of Q2. The end-result expectation (of the exercise) is a programmatically feasible and scientifically relevant AIT-NEO conceptual design that is aligned with available funds.